日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin's lymphoma weighing ≤70 kg

一项 IV 期、随机、多中心、开放标签试验，旨在比较标准体重剂量与固定剂量普乐沙福联合粒细胞集落刺激因子 (G-CSF) 治疗体重 ≤70 kg 的非霍奇金淋巴瘤患者的疗效和全身暴露量。

期刊:Bone Marrow Transplantation
影响因子:5.2
doi:10.1038/s41409-018-0253-y
Kuruvilla, John; Tzeng, Cheng-Hwai; Cho, Seok-Goo; Kim, Seok Jin; Tang, Jih-Luh; Su, Yaming; Wu, Jingyang; Vargo, Rita; Cheverton, Peter
细胞生物学
淋巴瘤
G-CSF
粒细胞
发表日期：2019
文献求助 收藏

Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study

NOVEL 研究结果显示，在对伊马替尼耐药或不耐受的慢性期或加速期慢性粒细胞白血病患者中，尼洛替尼在常规临床实践中的安全性和有效性：

期刊:Therapeutic Advances in Hematology
影响因子:3.1
doi:10.1177/2040620718756603
Kuo, Ching-Yuan; Wang, Po-Nan; Hwang, Wen-Li; Tzeng, Cheng-Hwai; Bai, Li-Yaun; Tang, Jih-Luh; Chang, Ming-Chih; Lin, Sheng-Fung; Chen, Tsai-Yun; Chen, Yeu-Chin; Tan, Tran-Der; Hsieh, Chih-Yi; Lin, Chinjune; Lai, Clinton; Miljkovic, Darko; Chang, Cheng-Shyong
白血病
细胞生物学
粒细胞
发表日期：2018
文献求助 收藏

Prognostic Factors on the Graft-versus-Host Disease-Free and Relapse-Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation

成人异基因造血干细胞移植后移植物抗宿主病无进展生存期和无复发生存期的预后因素

期刊:Stem Cells International
影响因子:3.3
doi:10.1155/2016/5143071
Liu, Yao-Chung; Chien, Sheng-Hsuan; Fan, Nai-Wen; Hu, Ming-Hung; Gau, Jyh-Pyng; Liu, Chia-Jen; Yu, Yuan-Bin; Hsiao, Liang-Tsai; Chiou, Tzeon-Jye; Tzeng, Cheng-Hwai; Chen, Po-Min; Liu, Jin-Hwang
细胞生物学
发育与干细胞
干细胞
发表日期：2016
文献求助 收藏

Enterovesical fistula caused by regressive change of non-Hodgkin's lymphoma: A case report

非霍奇金淋巴瘤消退性改变引起的肠膀胱瘘：病例报告

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2016.4561
Lee, Yu-Ting; Chen, Ying-Yuan; Wu, Chia-Yun; Chen, Hung-Ming; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye
淋巴瘤
发表日期：2016
文献求助 收藏

Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients

与利妥昔单抗治疗的非霍奇金淋巴瘤患者乙肝表面抗原逆转相关的人类细胞因子基因变异

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000003064
Hsiao, Liang-Tsai; Wang, Hao-Yuan; Yang, Ching-Fen; Chiou, Tzeon-Jye; Gau, Jyh-Pyng; Yu, Yuan-Bin; Liu, Hsiao-Ling; Chang, Wen-Chun; Chen, Po-Min; Tzeng, Cheng-Hwai; Chan, Yu-Jiun; Yang, Muh-Hwa; Liu, Jin-Hwang; Huang, Yi-Hsiang
细胞生物学
淋巴瘤
Human
免疫/内分泌
发表日期：2016
文献求助 收藏

Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study

非霍奇金淋巴瘤患者第二原发性恶性肿瘤的发生：一项全国性人群研究

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-015-1979-1
Chien, Sheng-Hsuan; Liu, Chia-Jen; Hong, Ying-Chung; Teng, Chung-Jen; Hu, Yu-Wen; Ku, Fan-Chen; Yeh, Chiu-Mei; Chiou, Tzeon-Jye; Gau, Jyh-Pyng; Tzeng, Cheng-Hwai
肿瘤
淋巴瘤
肿瘤免疫
发表日期：2015
文献求助 收藏

Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan

台湾一项基于人群的队列研究（98,876例患者）显示，结直肠癌后第二原发性恶性肿瘤的发生率存在结肠癌和直肠癌之间的差异，并探讨了合并症与第二原发性恶性肿瘤之间的关联。

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000001079
Lee, Yu-Ting; Liu, Chia-Jen; Hu, Yu-Wen; Teng, Chung-Jen; Tzeng, Cheng-Hwai; Yeh, Chiu-Mei; Chen, Tzeng-Ji; Lin, Jen-Kou; Lin, Chun-Chi; Lan, Yuan-Tzu; Wang, Huann-Sheng; Yang, Shung-Haur; Jiang, Jeng-Kai; Chen, Wei-Shone; Lin, Tzu-Chen; Chang, Shih-Ching; Chen, Ming-Huang; Teng, Hao-Wei; Liu, Jin-Hwang; Yen, Chueh-Chuan
肿瘤
肠癌
肿瘤免疫
发表日期：2015
文献求助 收藏

Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study

卵巢癌患者缺血性卒中风险：一项全国性人群研究

期刊:BMC Medicine
影响因子:8.3
doi:10.1186/1741-7015-12-53
Kuan, Ai-Seon; Teng, Chung-Jen; Wu, Hua-Hsi; Su, Vincent Yi-Fong; Chen, Yung-Tai; Chien, Sheng-Hsuan; Yeh, Chiu-Mei; Hu, Li-Yu; Chen, Tzeng-Ji; Tzeng, Cheng-Hwai; Liu, Chia-Jen
中风
肿瘤
肿瘤免疫
心血管
卵巢癌
发表日期：2014
文献求助 收藏

Comparison of cetuximab to bevacizumab as the first-line bio-chemotherapy for patients with metastatic colorectal cancer: superior progression-free survival is restricted to patients with measurable tumors and objective tumor response--a retrospective study

西妥昔单抗与贝伐珠单抗作为转移性结直肠癌患者一线生物化疗的比较：无进展生存期优势仅限于肿瘤可测量且有客观肿瘤反应的患者——一项回顾性研究

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-014-1741-0
Yang, Yuan-Hao; Lin, Jen-Kou; Chen, Wei-Shone; Lin, Tzu-Chen; Yang, Shung-Haur; Jiang, Jeng-Kai; Lan, Yuan-Tzu; Lin, Chun-Chi; Yen, Chueh-Chuan; Tzeng, Cheng-Hwai; Teng, Hao-Wei
肿瘤
肠癌
肿瘤免疫
发表日期：2014
文献求助 收藏

Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism.

替西罗莫司通过 CIP2A 依赖性机制增强西妥昔单抗在结肠癌中的疗效

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-014-1596-4
Wang Hsei-Wei, Yang Shung-Haur, Huang Guan-Da, Lin Jen-Kou, Chen Wei-Shone, Jiang Jeng-Kai, Lan Yuan-Tzu, Lin Chun-Chi, Hwang Wei-Lun, Tzeng Cheng-Hwai, Li Anna Fen-Yau, Yen Chueh-Chuan, Teng Hao-Wei
肿瘤
肠癌
发表日期：2014
文献求助 收藏